WuXi Biologics (Cayman) logo
WuXi Biologics (Cayman)
WXIBF | OTC
Chart Builder DCF Calculator
$5.94
-$0.21 (-3.41%)
At close: Nov 16, 2026, 1:57 PM ET
$6.00
+$0.06 (+1.01%)
Pre-market: Nov 16, 2026, 8:05 AM ET

WuXi Biologics (Cayman) Company Profile

Company profile explained

Company Profile

WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in China, North America, Europe, and other international markets. The company also offers expert consultation in biopharmaceutical technology, facilitates international sales contracting, develops and performs advanced testing services, and manages sales and marketing initiatives. Furthermore, it provides clinical and manufacturing support for biologics, manufactures and distributes medical products, serves as a contract development and manufacturing organization (CDMO) for vaccines, and functions as a material supplier. WuXi Biologics maintains significant strategic collaborations with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc. The organization, founded in 2014, is headquartered in Wuxi, China.

Key Executives

Name Position
Jian Dong Chief Executive Officer of WuXi Vaccines
Zhisheng Chen Chief Executive Officer & Executive Director
Lihua Yu Chief Operating Officer & Senior Vice President
Ming Tu Chief Financial Officer & Executive Vice President
Angus Scott Marshall Turner Senior Vice President and Head of Global BD & Alliance Management
Ge Li Founder & Chairman
He Wang General Counsel, Chief Compliance Officer, SVP and Head of Legal & Compliance Department
Jijie Gu Chief Scientific Officer & President of Global Biologics Research
Lina Fan Senior Vice President & Head of Investor Relations
Xiaohui Liu Executive VP & Chief Human Resources Officer
Xuejun Gu CTO, Chief Client Officer, EVP of Global Biologics Development Department & Executive Director
WuXi Biologics (Cayman)
WuXi Biologics (Cayman) logo
Country China
IPO Date Jan 30, 2018
Industry Biotechnology
Sector Healthcare
Employees 13,252
CEO Zhisheng Chen

Contact Details

No. 108, Meiliang Road Wuxi, JS 214092 China

Stock Details

Ticker Symbol WXIBF
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number G97008117
ISIN Number KYG970081173
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.